Switzerland· 62481001
Zoledronat Fresenius Onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
A zoledronic acid product containing acidum zoledronicum, registered in Switzerland by Fresenius Kabi (Schweiz) AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Zoledronic acid is registered in 14 of 19 countries.
Countries holding a registration under ATC M05BA08 (zoledronic acid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Zoledronic acid · ATC M05BA08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zoledronic acid costs, country by country.
Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.
- Switzerland: $212.85 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Zoledronic acid · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$212.85
The record
At a glance
Swissmedic (Switzerland)- Active substance
- acidum zoledronicum
- Manufacturer
- Fresenius Kabi (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- M05BA08
- ATC class
- Zoledronic acid
- Defined daily dose
- 4 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680624810013Durchstf 5 mlCHF 124
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
251 interactions on record for zoledronic acid.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zoledronic acid · interactions on record
251 records
- 12 severe
- 57 moderate
- 180 info
Most severe, free to view
- EtelcalcetideH05BX04severe
- SirolimusL01EG04severe
- SirolimusL04AA10severe
- TacrolimusL04AD02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zoledronic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAcido zoledronico Actavis 4 mg/5 ml concentrado para solucion para perfusion EFGActavis Group Ptc Ehf.
- IrelandZoledronic Acid Teva 4 mg/5 ml concentrate for solution for infusionTeva Pharma B.V.
- FinlandAclastaSandoz Pharmaceuticals d.d.
- United StatesReclastSandoz Inc
- United KingdomAclasta 5mg/100ml solution for infusion bottlesSandoz Ltd
- BelgiumAcide Zoledronique Regiomedica 4 mg/5 mlRegiomedica
- GermanyAszoraAnwerina Deutschland Gmbh
- CzechiaACLASTASandoz Pharmaceuticals d.d., Ljubljana
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
- Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
- Cyprus · Nordeloz, Zoledronic Acid Altan
- Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
- Germany · Aszora, Clastizol
- Denmark · Zoledo, Zoledronsyre Fresenius Kabi
- Estonia · Zoledronic Acid Fresenius Kabi
- Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Finland · Zobiore, Zoledronic Acid Fresenius Kabi
- France · Acide Zoledronique Altan, Acide Zoledronique Biogaran
- United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
- Greece · Bonevin, Nordeloz
- Croatia · Zolenat
- Hungary · Osporil, Zoledronsav Fresenius Kabi
- Ireland · Zerlinda, Zoledronic Acid
- Iceland · Aclasta, Aszora
- Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
- Liechtenstein · Aclasta, Zoledronic Acid Accord
- Lithuania · Zoledronic Acid Fresenius Kabi
- Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Latvia · Zoledronic Acid Fresenius Kabi
- Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
- Norway · Aclasta, Zoledo
- Poland · Osporil, Zerlinda
- Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
- Sweden · Zerlinda, Zoledronic Acid Accord
- Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
- Slovakia · Kyselina, Kyselina Zoledrónová Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba897bf4-4649-4f74-a89e-2e6a69df0dbc GET /v1/drugs/ba897bf4-4649-4f74-a89e-2e6a69df0dbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "acidum zoledronicum 4 mg",
"valid_from": "2013-05-01",
"limitations": null,
"galenic_form": "Inf Konz 4 mg/5ml",
"therapeutic_area": null,
"sl_inclusion_date": "2013-05-01",
"self_retention_pct": 10
}See everything about zoledronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.